Most Recent

The Yeast Two-hybrid Assay

By | August 29, 2005

No protein is an island.


The Human Interactome Falls into place

By | August 1, 2005

a first draft, so to speak, of protein-protein interactions, the subject of the story on the pages that follow.


Another Kind of Antigen

By | July 18, 2005

The discovery that lipids can serve as antigens first stunned the immunological community a decade ago.


For most, immunity is simply there when you need it, like the umbrella sitting by the door.


Stem Cells... An Emerging Portrait

By | July 4, 2005

Human embryonic stem cells remain the focus of an ever-intensifying public debate that blurs the limits of biology, confusing cultured tissues with children, and blastocysts descended from fertilized ova with those derived from somatic cell nuclei.


Trials of the Heart

By | July 4, 2005

Adult human stem cells may offer the opportunity to use one of biomedical science's most promising technologies without the ethical dilemmas of embryonic cells.


Tricks For Human Embryonic Stem Cells

By | July 4, 2005

Your stem cells have just arrived.


The Hum and the Genome

By | June 6, 2005

The air at the Wellcome Trust Sanger Institute in Hinxton, near Cambridge, fairly hums with electricity.


It's more than simple databasing, mining, or in silico experimentation.


Neurophysiology: Dust Clearing on the Long-Term Potentiation Debate

By | May 23, 2005

Three decades and 6,000 papers since the term was first coined, scientists are still debating the mechanisms of long-term potentiation (LTP).1 Defined in 1973 as an increase in synaptic strength following experimentally induced high-frequency stimulation,2 LTP has been consistently controversial. Now at last, "There is a consensus beginning to emerge," says Columbia University Nobel laureate, Eric Kandel, as years of research have begun to make sense of what once seemed irreconcilable contradict

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.